Technical Strength Analyser      Futures Screeners ,    Option Screeners
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Laurus Labs , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Laurus Labs Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

CodeLAURUSLABS
EOD Share Price438.6
Previous Share Price430.1
Price Change 8.50
Change % 1.98%
Volume190.69 K
Five Day Avg Vol225.08 K
Beta0.0
Last Business Date19-Feb-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week -1.05 -0.239
Two Weeks 0.900 0.206
One Month 32.70 8.06
Three Months 97.40 28.55
Six Months 99.40 29.30
One Year 108.20 32.75

Highs / Lows

DurationHighLow
One Week453.3360.0
Two Weeks453.3360.0
One Month459.95360.0
Three Months459.95326.6
Six Months459.95303.3
One Year459.95303.3

Key Moving Average

MA SMAEMA
5 Days 437.11436.546
15 Days 435.713433.247
20 Days 433.545429.66
50 Days 400.859407.142
100 Days 373.555386.398
200 Days 360.777376.534
Detailed MA Analysis of LAURUSLABS ...

Key Technical Indicators

MACD 10.13
RSI 58.84
RSI (Smooth) 63.17
ADX 46.88
Chaikin Money Flow -0.122
Williams %R -15.76
PSAR 456.45
Detailed Tech Analysis LAURUSLABS ...

Financial Data Highlights

Market Cap4672.07
Book Value/ Share151.708
Enterprise Value1085.92
Revenue TTM2627.74
Gross Profit TTM1027.46
Revenue /Share TTM246.70
Consensus Target559.67
Key Financial Highlights LAURUSLABS ...

Financial Ratios of LAURUSLABS

EPS17.66
PE25.11
Div/Share1.50
Div Yield0.340
Trailing PE25.11
Forward PE18.97
Price/Book2.92
Key Financial Ratios of LAURUSLABS ...

Key Profit & Loss Data

Period31_Mar_2019Growth
Net Inc 93.76 44.06 %
Ops Income218.83 26.42 %
Revenue2291.92 11.47 %
Ops Expense2073.09 17.87 %
PBT119.75 49.56 %
Gross Profit1027.46 5.71 %
Div Paid-15.90 0.252 %
Key P&L LAURUSLABS ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR85.9019.59
Week PR85.9019.59
Month PR93.3021.27
5 Day Period29.477.83
10 Day Period20.395.16
5 Week Period30.047.19
3 Months Period70.0218.83
Price Range /Volatility LAURUSLABS ...

Highlights & Chart Patterns of Laurus Labs Ltd.

Current price is within 5.0% of One Year High of 459.95 touched on 31-Jan-20.
Stock has jumped by more than 10% in last two weeks from its lowest level of 360.0 dt 19-Feb-20
Stock has jumped by more than 15% in last One Month from its lowest level of 360.0 dt 19-Feb-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 326.6 dt 21-Nov-19.
Share has hit One Month high on 19-Feb-20.
Share is making strong moves on recent days daily chart. Such movements may give an opportunity for short term trading.
Bearish engulfing Candlestick pattern was formed by Laurus Labs Ltd. on 18/02/2020
More Chart Patterns Laurus Labs Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Laurus Labs Ltd.

Date Open High Low Close Volume
19-Feb-20 432.55 445.90 360.00 438.60 190 K
18-Feb-20 439.10 439.10 422.55 430.10 99956
17-Feb-20 438.10 441.90 435.20 438.40 78918
14-Feb-20 444.00 444.25 435.50 437.15 139 K
13-Feb-20 441.00 453.30 438.05 441.30 616 K
12-Feb-20 439.00 445.00 433.10 439.65 372 K
11-Feb-20 438.00 448.90 434.05 436.15 244 K
10-Feb-20 442.90 448.95 434.70 435.80 208 K
07-Feb-20 440.20 445.50 436.15 438.95 156 K
06-Feb-20 442.00 442.00 435.55 437.70 145 K
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in India and internationally. It operates through Laurus Generics APIs, Laurus Generics Finished Dosage Forms (FDF), Laurus Synthesis, and Laurus Ingredients divisions. The Laurus Generics APIs division develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), Hepatitis C, cardiovascular, antidiabetic, anti-asthmatic, gastroenterology, oncology, and ophthalmic therapeutic areas. The Laurus Generics Finished Dosage Forms division develops and manufactures oral solid formulations, such as ARVs, anti-diabetic, cardiovascular, and proton pump inhibitors. The Laurus Synthesis division provides contract development and manufacturing services for pharmaceutical companies. The Laurus Ingredients division manufactures and sells specialty ingredients for use in the nutraceutical, dietary supplements and cosmeceutical products. In addition, the company offers chemistry, IP development, business support, and related services to the pharmaceutical community. Laurus Labs Limited has a strategic collaboration with Global Fund to provide the treatment of HIV/AIDS. The company was incorporated in 2005 and is based in Hyderabad, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.